Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Filament Health Corp (OP:FLHLF)

0.0001 UNCHANGED
Last Price Updated: 11:58 AM EST, Dec 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Filament Health Corp

< Previous 1 2 3 Next >
News headline image
Psychedelic Research Expands In Australia With Palliative Care Partnership & New MDMA Analog Portfolio ↗
Psyence Partners with iNGENū for Palliative Care Clinical Trial 
Via Benzinga
News headline image
Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More ↗
Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered 
Via Benzinga
News headline image
Psychedelic Trials Update: Treating Meth Addiction, Fibromyalgia & General Anxiety Disorder ↗
Three companies have provided updates on their efforts to assess different psychedelics for treating a widely varied set of conditions. 
Via Benzinga
News headline image
Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More ↗
Two Bills Approved By Hawaii Senators With Governor's Endorsement Hawaii Senate Ways and Means Committee approved a pair of bills aiming to promote and investigate the therapeutic potential of MDMA and... 
Via Benzinga
News headline image
[Video] Revolutionizing Mental Health: Filament Health CEO Discusses The Future Of Psychedelic Medicine ↗
Cannabis enthusiasts and industry insiders alike will find the latest episode of Benzinga's Cannabis Insider show both informative and engaging. 
Via Benzinga
News headline image
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More ↗
Psychedelics States Reform: Utah, Iowa, Missouri and Oklahoma’s New Bills; Hawaii, Arizona and Washington's Green Lights, New Hampshire's Setback Earlier this week, three bills were introduced and... 
Via Benzinga
News headline image
Supply Partnerships: Filament's Psilocybin Trial In Canada, PharmAla's MDMA Program In Australia ↗
Filament’s Psilocybin, Tested On Mild Cognitive Impairment By CAMH 
Via Benzinga
News headline image
EXCLUSIVE: Defining 'Natural' Psychedelics, State Regulations & Ayahuasca's Benefits ↗
(Part three of a three-part series) See previous stories: EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans 
Via Benzinga
News headline image
Psyched: States With Psychedelics Legalization Bills, Next-Gen Molecule For Addiction Treatment And More ↗
Legalizing Psychedelics From New York To Washington And Five In Between: Which State Will Go First? 
Via Benzinga
News headline image
Jaguar Health Announces Establishment of Board of Directors for Newly Formed Joint Venture Magdalena Biosciences
Via ACCESSWIRE
News headline image
Psychiatry And Business Collaborate: European Psychedelics Trial Tackles Alcohol Addiction ↗
Clinical-stage natural psychedelics developer Filament Health (OTCQB: FLHLF) and the Psychiatric Center Copenhagen’s collaborative clinical trial has been approved by the Danish Medicines Agency and is... 
Via Benzinga
News headline image
6 Psychedelics Companies Take Action: Here Are The Latest, Major Announcements ↗
Second week of 2023, and business is up and running. Let’s take a look at the announcements shared by some of the companies in the psychedelics space. 
Via Benzinga
News headline image
Jaguar Health and Filament Health, with Funding from One Small Planet, Form Joint Venture Magdalena Biosciences to Develop Botanical Pharmaceutical Drug Candidates for Mental Health Illnesses
Via ACCESSWIRE
News headline image
Psyched: First Ayahuasca Pill Created, Psychedelics Legalization Predicted, UK's Research Support And More ↗
Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans The first medical-grade drug candidate of the psychedelic ayahuasca is being developed. 
Via Benzinga
News headline image
EXCLUSIVE: The Psychedelics Debate Is 'Raging' As Filament Debuts Ayahuasca Pill ↗
Part two of a three-part series. Previous story: Standardized Ayahuasca Pill Is Officially Here, Feast Yourself With The Exclusive Details & Insights 
Via Benzinga
News headline image
KCSA Mental Health Virtual Investor Conference: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Psychedelics Company Filament Signs Licensing Deal With Psyence In US, UK And EU ↗
Filament Health Corp. (OTCQB: FLHLF) and Psyence Group Inc. (OTCQB: PSYGF) have inked a worldwide commercial licensing deal. 
Via Benzinga
News headline image
EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans ↗
Part one of a three-part series. The first medical-grade drug candidate of the psychedelic ayahuasca is being developed. 
Via Benzinga
News headline image
KCSA Mental Health Virtual Investor Conference Agenda Announced for December 15th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Filament Health to Present Live at VirtualInvestorConferences.com December 15th
Filament invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) Featured in Virtual Coverage of the KCSA Mental Health Investor Conference
Via Investor Brand Network
Topics Intellectual Property
News headline image
Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project ↗
Psychedelic Research & Fed Funding By The National Institute Of Mental Health The National Institute of Mental Health (NIMH) named the types of psychedelics studies to which it would grant funds and... 
Via Benzinga
News headline image
Natural Psychedelics Extraction & Standardization Obtains Two New US Patents ↗
Clinical-stage psychedelics drug development company Filament Health Corp. 
Via Benzinga
News headline image
Psyched: Colorado Legalizes Psychedelics, NYC Treats Alcoholism With Ketamine, $30M Series A For Startup ↗
Colorado Voters Approve Initiative To Legalize And Regulate Psychedelics 
Via Benzinga
News headline image
Filament Health Shares Q3 2022 Results, On Road To Becoming Industry's Natural Psilocybin Supplier ↗
Clinical-stage natural psychedelic drug development company Filament Health Corp. (OTCQB: FLHLF) reported its third quarter financial results and operational highlights for the period ended September... 
Via Benzinga
News headline image
Psyched: Brock Pierce Joins Psychedelic VC, Colorado's Psychedelics Legalization, Zappy Zapolin's Open Letter & More ↗
Crypto Billionaire Brock Pierce Joins Psychedelic Venture Fund, Says 'Potential Reward Is Immeasurable' 
Via Benzinga
News headline image
EXCLUSIVE: Crypto Billionaire Brock Pierce Joins Psychedelic Venture Fund, Says 'Potential Reward Is Immeasurable' ↗
Brock Pierce, the crypto billionaire, economist and philanthropist serving as chairman of the Bitcoin Foundation, has joined Jeremy Gardner’s psychedelics-focused venture fund Mystic Ventures as a... 
Via Benzinga
News headline image
Filament Begins First Ever FDA-Approved Clinical Trial On Naturally-Derived Psychedelic Drugs ↗
Clinical-stage natural psychedelics company Filament Health Corp. 
Via Benzinga
News headline image
Canadian Special Access Program Further Authorizes Novel Psychedelic Drugs For Emergency Treatments ↗
For those unaware, Canada provides a legal way for patients presenting unresolved mental health issues to receive psychedelic-assisted treatment. 
Via Benzinga
News headline image
Filament Health Announces First Dosing in Groundbreaking FDA-Approved Psilocin Clinical Trial
From Filament Health Corp.
Via Business Wire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.